Exclusive: FDA chief had 'robust discussion' with White House about vaccine timelines
U.S.
December 4, 20204 min read725 words
Published: December 4, 2020  |  4 min read725 words
By , WASHINGTON (Reuters) - The U.S. Food and Drug Administration’s chief had a “robust discussion” with the White House this week about the timeline for coronavirus vaccine approvals and believes vaccinating 20 million Americans this year is realistic, he said on Friday.FDA Comm...
Exclusive: FDA chief had 'robust discussion' with White House about vaccine timelines Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
13 reviews
img-trusted
78%
public score
58 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.